Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Adam J. Rose, Susan L. Greenspan & Guneet K. Jasuja. (2023) Gaps in evidence on treatment of male osteoporosis: a Research Agenda. The Aging Male 26:1.
Read now
Read now
Georg Zdolsek, Yupei Chen, Hans-Peter Bögl, Chunliang Wang, Mischa Woisetschläger & Jörg Schilcher. (2021) Deep neural networks with promising diagnostic accuracy for the classification of atypical femoral fractures. Acta Orthopaedica 92:4, pages 394-400.
Read now
Read now
Eric D. Van Baarsel, Vandan Patel, Yazeed Kesbeh, Huthayfa Kahf & Nicholas Alonzo. (2019) Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review. Journal of Community Hospital Internal Medicine Perspectives 9:4, pages 340-343.
Read now
Read now
Daniel C Austin, Michael T Torchia, Christian M Klare & Robert V Cantu. (2017) Atypical femoral fractures mimicking metastatic lesions in 2 patients taking denosumab. Acta Orthopaedica 88:3, pages 351-353.
Read now
Read now
Zeina A. Habib. (2017) Bisphosphonates in the treatment of osteoporosis: a review of skeletal safety concerns. Expert Review of Endocrinology & Metabolism 12:1, pages 59-71.
Read now
Read now
Maurizio Rossini, Giovanni Adami, Silvano Adami, Ombretta Viapiana & Davide Gatti. (2016) Safety issues and adverse reactions with osteoporosis management. Expert Opinion on Drug Safety 15:3, pages 321-332.
Read now
Read now
Gilbert R. Kaats, Harry G. Preuss, Sidney Stohs & Nicholas Perricone. (2016) A 7-Year Longitudinal Trial of the Safety and Efficacy of a Vitamin/Mineral Enhanced Plant-Sourced Calcium Supplement. Journal of the American College of Nutrition 35:2, pages 91-99.
Read now
Read now
Davide Gatti, Silvano Adami, Ombretta Viapiana & Maurizio Rossini. (2015) The use of bisphosphonates in women: when to use and when to stop. Expert Opinion on Pharmacotherapy 16:16, pages 2409-2421.
Read now
Read now
Justine Yun Yu Lee, Tamara Soh, Tet Sen Howe, Joyce Suang Bee Koh, Ernest Beng Kee Kwek & David Thai Chong Chua. (2015) Bisphosphonate-associated peri-implant fractures: a new clinical entity?. Acta Orthopaedica 86:5, pages 622-626.
Read now
Read now
Articles from other publishers (123)
Jörg Schilcher, Alva Nilsson, Oliver Andlid & Anders Eklund. (2024) Fusion of electronic health records and radiographic images for a multimodal deep learning prediction model of atypical femur fractures. Computers in Biology and Medicine 168, pages 107704.
Crossref
Crossref
Takumi Imai, Takayuki Hosoi, Hiroshi Hagino, Takanori YamamotoTatsuhiko Kuroda, Hiroshi Watanabe & Shiro Tanaka. (2023) Antiresorptive Drugs and the Risk of Femoral Shaft Fracture in Men and Women With Osteoporosis: A Cohort Study Using the National Database of Health Insurance Claims of Japan. Journal of Epidemiology 33:12, pages 633-639.
Crossref
Crossref
Jiajia Wu, Song Yuan, Yuxiang Jiang, Yinnong Jia, Chunyu Ji, Zhuomin Tan, Wenquan Shi & Zhili Peng. (2023) Alendronate-derived carbon dots for bioimaging and effective osteoblastic differentiation induction and promotion. Diamond and Related Materials 140, pages 110571.
Crossref
Crossref
Chun Ho Wong, Andy Ka Chun Kan, Kimberly Hang Tsoi, Stacey Sheung Yi Chan, Nancy Su Jiang, Connie Hong Nin Loong, Carol Ho Yi Fong, Janus Siu Him Wong, Graham Ka Hon Shea, Ching Lung Cheung, Chi Ho Lee, Kathryn Choon Beng Tan, Yu Cho Woo & David Tak Wai Lui. (2023) Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis. Endocrine.
Crossref
Crossref
Mawson Wang & Markus J Seibel. (2023) Approach to the Patient With Bone Fracture: Making the First Fracture the Last. The Journal of Clinical Endocrinology & Metabolism 108:12, pages 3345-3352.
Crossref
Crossref
Bárbara Gehrke, Maria Caroline Alves Coelho, Catarina Brasil d'Alva & Miguel Madeira. (2023) Long-term consequences of osteoporosis therapy with bisphosphonates. Archives of Endocrinology and Metabolism 68.
Crossref
Crossref
Elpiniki Rentzeperi, Stavroula Pegiou, Ioannis Tsakiridis, Ioannis Kalogiannidis, Anargyros Kourtis, Apostolos Mamopoulos, Apostolos Athanasiadis & Themistoklis Dagklis. (2023) Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines. Obstetrical & Gynecological Survey 78:11, pages 657-681.
Crossref
Crossref
Ines Foessl, Hans P. Dimai & Barbara Obermayer-Pietsch. (2023) Long-term and sequential treatment for osteoporosis. Nature Reviews Endocrinology 19:9, pages 520-533.
Crossref
Crossref
Joan C. Lo, Wei Yang, Jennifer J. Park-Sigal & Susan M. Ott. (2023) Osteoporosis and Fracture Risk among Older US Asian Adults. Current Osteoporosis Reports.
Crossref
Crossref
Ryan J Schroeder, Julia Staszkiewicz, Collyn O'Quin, Brandon Carroll, Nicolette Doan, Sagar Patel, Shahab Ahmadzadeh, Anusha Kallurkar, Omar Viswanath, Giustino Varrassi, Sahar Shekoohi & Alan D Kaye. (2023) Oral Therapeutics Post Menopausal Osteoporosis. Cureus.
Crossref
Crossref
Yao Xiao, Yiqian Chen, Yan Huang & Yuan Xiao. (2023) Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system. Scientific Reports 13:1.
Crossref
Crossref
Hong Jin Kim, Ha Kyun Chang, Dong-Gune Chang, JiYun Ha, Byeong-Rak Keum & Gun-Hwa Kim. (2023) Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures. Journal of Clinical Medicine 12:11, pages 3820.
Crossref
Crossref
Yong Bum Joo, Yoo Sun Jeon, Woo Yong Lee & Hyung Jin Chung. (2023) Risk Factors Associated with Intraoperative Iatrogenic Fracture in Patients Undergoing Intramedullary Nailing for Atypical Femoral Fractures with Marked Anterior and Lateral Bowing. Medicina 59:4, pages 735.
Crossref
Crossref
Yue Wu, Yunjiao Yang, Lan Wang, Yiding Chen, Xuke Han, Lisha Sun, Huizhen Chen & Qiu Chen. (2023) Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism. Frontiers in Endocrinology 14.
Crossref
Crossref
Ifaz T. Haider, Lindsay L. Loundagin, Andrew Sawatsky, Paul J. Kostenuik, Steven K. Boyd & W. Brent Edwards. (2023) Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys. Journal of Bone and Mineral Research 38:3, pages 403-413.
Crossref
Crossref
Chelsea Ayers, Devan KansagaraBrittany LazurRongwei FuAmy Kwon & Curtis Harrod. (2023) Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Annals of Internal Medicine 176:2, pages 182-195.
Crossref
Crossref
Louise Woon Theng Lo, Joyce Suang Bee Koh, Tet Sen Howe, Meng Ai Png & Ngai Nung Lo. (2023) Incomplete Periprosthetic Atypical Femoral Fracture With Concomitant Hip and Knee Arthroplasties. JBJS Case Connector 13:1.
Crossref
Crossref
Meng Ai Png, Joyce Suang Bee Koh, P. Chandra Mohan, Choong Yin Howe & Tet Sen Howe. (2022) Factors affecting healing and progression of conservatively treated incomplete atypical femoral fractures: retrospective observational study. Journal of Bone and Mineral Metabolism 41:1, pages 61-73.
Crossref
Crossref
Xue-wei Yao, He-dong Liu, Mao-xian Ren, Tian-lin Li, Wen-kai Jiang, Zhi Zhou, Zhi-yi Liu & Min Yang. (2022) Aloe polysaccharide promotes osteogenesis potential of adipose-derived stromal cells via BMP-2/Smads and prevents ovariectomized-induced osteoporosis. Molecular Biology Reports 49:12, pages 11913-11924.
Crossref
Crossref
Shunji Okita, Taichi Saito, Norio Yamamoto, Yusuke Mochizuki, Ryuichi Nakahara, Yasunori Shimamura, Toshiyuki Kunisada, Keiichiro Nishida & Toshifumi Ozaki. (2022) Five cases of atypical ulnar fractures associated with long-term bisphosphonate use: An anatomical and mechanical analysis using a finite element model. Journal of Orthopaedic Science.
Crossref
Crossref
Rui Zhao, Tieliang Shang, Bo Yuan, Xiangdong Zhu, Xingdong Zhang & Xiao Yang. (2022) Osteoporotic bone recovery by a bamboo-structured bioceramic with controlled release of hydroxyapatite nanoparticles. Bioactive Materials 17, pages 379-393.
Crossref
Crossref
Youngho Cho & Jae Uk Shin. (2022) Bilateral Subtrochanteric Complete Atypical Femoral Fracture in a Patient With Rheumatoid Arthritis: A Case Report. Cureus.
Crossref
Crossref
L.U. Gani, N.F. Anthony, L.M. Dacay, P.T. Tan, L.R. Chong & T.F.J. King. (2022) Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population – Secondary analysis. Bone 162, pages 116455.
Crossref
Crossref
Wei Zhou, Hanh H. Nguyen, Denise M. van de Laarschot, Tet Sen Howe, Joyce S.B. Koh, Frances Milat, Jeroen G.J. van Rooij, Joost A.M. Verlouw, Bram C.J. van der Eerden, Mark Stevenson, Rajesh V. Thakker, M. Carola Zillikens & Peter R. Ebeling. (2022)
Whole Exome Sequencing in Two
Southeast
Asian Families With Atypical Femur Fractures
. JBMR Plus 6:8.
Crossref
Crossref
Annette L. Adams, Denison S. Ryan, Anna Lawless & Heidi Fischer. (2022) Bisphosphonate Drug Holiday and Fracture Risk: Reviewing the Evidence. Current Treatment Options in Rheumatology 8:3, pages 37-55.
Crossref
Crossref
Soo Min Cha, Hyun Dae Shin, Seung Hoo Lee & Jae Woo Shin. (2022) Radiological Reversibility of Incomplete Atypical Femoral Fracture with Cessation of Bisphosphonate: Including an Early Stage of Incomplete Fracture. Indian Journal of Orthopaedics 56:6, pages 1023-1032.
Crossref
Crossref
Mawson Wang, Yu‐Fang Wu & Christian M. Girgis. (2022) Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real‐World Studies. JBMR Plus 6:6.
Crossref
Crossref
Nitesh D Dhanekula, Gareth Crouch, Karen Byth, Sue Lynn Lau, Albert Kim, Edward Graham, Andrew Ellis, Roderick J Clifton‐Bligh & Christian M Girgis. (2022) Asian Ethnicity and Femoral Geometry in Atypical Femur Fractures: Independent or Interdependent Risk Factors?. JBMR Plus 6:4.
Crossref
Crossref
Kaleen N. Hayes, Kevin A. Brown, Angela M. Cheung, Sandra A. Kim, David N. JuurlinkSuzanne M. Cadarette. (2022) Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy. Annals of Internal Medicine 175:3, pages 335-343.
Crossref
Crossref
Dennis M. Black, Katherine Condra, Annette L. Adams & Richard Eastell. (2022) Bisphosphonates and the risk of atypical femur fractures. Bone 156, pages 116297.
Crossref
Crossref
Elisa Troiano, Tiziano Giacché, Andrea Facchini, Nicholas Crippa Orlandi, Matteo Cacioppo, Marco Saviori, Vanna Bottai, Francesco Muratori, Nicola Mondanelli & Stefano Giannotti. (2022) Surgical and Pharmacological Management of Periprosthetic Atypical Femoral Fractures: A Narrative Literature Review. Geriatric Orthopaedic Surgery & Rehabilitation 13, pages 215145932210903.
Crossref
Crossref
Marie‐Josée Bégin, Marie‐Claude Audet, Thierry Chevalley, Marina Portela, Ivan Padlina, Didier Hannouche, Kuntheavy Ing Lorenzini, Raphaël Meier, Robin Peter, Brigitte Uebelhart, René Rizzoli, Serge Ferrari & Emmanuel Biver. (2021) Fracture Risk Following an Atypical Femoral Fracture. Journal of Bone and Mineral Research 37:1, pages 87-94.
Crossref
Crossref
Ani Ural. (2021) Biomechanical mechanisms of atypical femoral fracture. Journal of the Mechanical Behavior of Biomedical Materials 124, pages 104803.
Crossref
Crossref
Seong-Eun Byun, Young-Ho Cho, Young-Kyun Lee, Jung-Wee Park, Seonguk Kim, Kyung-Hoi Koo & Young Soo Byun. (2021) Straight nail insertion through a laterally shifted entry for diaphyseal atypical femoral fractures with bowing: good indications and limitations of this technique. International Orthopaedics 45:12, pages 3223-3232.
Crossref
Crossref
J.-T. Kim, Y.-H. Cha, S. Jeong, J.-I. Yoo & C.H. Park. (2021) Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report. Osteoporosis International 32:10, pages 2115-2118.
Crossref
Crossref
K.D. Gu, B. Ettinger, C.D. Grimsrud & J.C. Lo. (2021) Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy. Osteoporosis International 32:10, pages 2119-2123.
Crossref
Crossref
Lanny V. Griffin, Elizabeth Warner, Saroj Palnitkar, Shijing Qiu, Mahalakshmi Honasoge, Shawna G. Griffin, George Divine & Sudhaker D. Rao. (2021) Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case‐Control Study. JBMR Plus 5:9.
Crossref
Crossref
Matthew Wong‐Pack, Kyra Cummings, Arthur Lau & Jonathan D. Adachi. 2021. Evidence‐Based Orthopedics. Evidence‐Based Orthopedics
37
50
.
Linsey Gani, Natasha Anthony, Lily Dacay, Pei Tan, Le Roy Chong & Thomas FJ King. (2021) Incidence of Atypical Femoral Fracture and Its Mortality in a Single Center in Singapore. JBMR Plus 5:8.
Crossref
Crossref
Nazia Ayub, Malak Faraj, Sam Ghatan, Joannes A. A. Reijers, Nicola Napoli & Ling Oei. (2021) The Treatment Gap in Osteoporosis. Journal of Clinical Medicine 10:13, pages 3002.
Crossref
Crossref
O. Pearce, T. Edwards, K. Al-Hourani, M. Kelly & A. Riddick. (2021) Evaluation and management of atypical femoral fractures: an update of current knowledge. European Journal of Orthopaedic Surgery & Traumatology 31:5, pages 825-840.
Crossref
Crossref
E. O. Billington, W. D. Leslie, J. P. Brown, J. C. Prior, S. N. Morin, C. S. Kovacs, S. M. Kaiser, B. C. Lentle, T. Anastassiades, T. Towheed & G. A. Kline. (2021) Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study. Osteoporosis International 32:7, pages 1313-1320.
Crossref
Crossref
Gareth Crouch, Nitesh D Dhanekula, Karen Byth, Emma Burn, Sue Lynn Lau, Lillias Nairn, Liza Nery, Jean Doyle, Edward Graham, Andrew Ellis, Roderick J Clifton‐Bligh & Christian M Girgis. (2021)
The Sydney
AFF
Score: A Simple Tool to Distinguish Females Presenting With Atypical Femur Fractures Versus Typical Femur Fractures
. Journal of Bone and Mineral Research 36:5, pages 910-920.
Crossref
Crossref
Douglas C. Bauer & Bo Abrahamsen. (2021) Bisphosphonate Drug Holidays in Primary Care: When and What to Do Next?. Current Osteoporosis Reports 19:2, pages 182-188.
Crossref
Crossref
Nicklas H. Rasmussen, Jakob Dal, Joop Van den Bergh, Frank de Vries, Morten Hasselstrøm Jensen & Peter Vestergaard. (2021) Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study. Current Drug Safety 16:1, pages 52-61.
Crossref
Crossref
Hiroyuki Tsuchie, Naohisa Miyakoshi, Yuji Kasukawa, Koji Nozaka, Kimio Saito, Hayato Kinoshita, Moto Kobayashi, Norio Suzuki, Toshiaki Aizawa, Hidekazu Abe, Shigeto Maekawa, Takenori Tomite, Yuichi Ono, Kentaro Ouchi, Nobusuke Shibata, Itsuki Nagahata, Masaaki Takeshima, Manabu Akagawa, Yusuke Yuasa, Chie Sato & Yoichi Shimada. (2021) Evaluation of the Nature and Etiologies of Risk Factors for Diaphyseal Atypical Femoral Fractures. Medical Principles and Practice 30:5, pages 430-436.
Crossref
Crossref
Robert A. Adler, Mariam A. Assaad & Ghada A. El-Hajj Fuleihan. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
1805
1825
.
Dong Kyu Moon, Bo Gyu Kim, A Ram Lee, Yeong In Choe, Imran Khan, Kyoung Mi Moon, Ryoung-Hoon Jeon, June-Ho Byun, Sun-Chul Hwang & Dong Kyun Woo. (2020) Resveratrol can enhance osteogenic differentiation and mitochondrial biogenesis from human periosteum-derived mesenchymal stem cells. Journal of Orthopaedic Surgery and Research 15:1.
Crossref
Crossref
Joan C. Lo, Romain S. Neugebauer, Bruce Ettinger, Malini Chandra, Rita L. Hui, Susan M. Ott, Christopher D. Grimsrud & Monika A. Izano. (2020) Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskeletal Disorders 21:1.
Crossref
Crossref
Y Yano, A Kuriyama, Y Yano, A Takeshita & H Hashizume. (2020) Atypical femoral fracture with bisphosphonate use. QJM: An International Journal of Medicine 113:11, pages 825-826.
Crossref
Crossref
Hans Peter Bögl, Georg Zdolsek, Karl Michaëlsson, Jonas Höijer & Jörg Schilcher. (2020) Reduced Risk of Reoperation Using Intramedullary Nailing with Femoral Neck Protection in Low-Energy Femoral Shaft Fractures. Journal of Bone and Joint Surgery 102:17, pages 1486-1494.
Crossref
Crossref
Mahmoud M Bakr, Wendy L Kelly, Athena R Brunt, Bradley C Paterson, Helen M Massa, Nigel A Morrison & Mark R Forwood. (2020) Intermittent Parathyroid Hormone Accelerates Stress Fracture Healing More Effectively Following Cessation of Bisphosphonate Treatment. JBMR Plus 4:9.
Crossref
Crossref
Denise L Jacobson, Jane C Lindsey, Catherine Gordon, Rohan Hazra, Hans Spiegel, Flavia Ferreira, Fabiana R Amaral, Jesica Pagano-Therrien, Aditya Gaur, Kathy George, Jane Benson & George K Siberry. (2020) Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age. Clinical Infectious Diseases 71:5, pages 1281-1288.
Crossref
Crossref
Hanh H. Nguyen, Amar Lakhani, Catherine Shore-Lorenti, Roger Zebaze, Amanda J. Vincent, Frances Milat & Peter R. Ebeling. (2020) Asian ethnicity is associated with atypical femur fractures in an Australian population study. Bone 135, pages 115319.
Crossref
Crossref
Denise M van de Laarschot, Malachi J McKenna, Bo Abrahamsen, Bente Langdahl, Martine Cohen-Solal, Núria Guañabens, Richard Eastell, Stuart H Ralston & M Carola Zillikens. (2020) Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society. The Journal of Clinical Endocrinology & Metabolism 105:5, pages 1682-1699.
Crossref
Crossref
H.P. Bögl, K. Michaëlsson, G. Zdolsek, J. Höijer & J. Schilcher. (2020) Increased rate of reoperation in atypical femoral fractures is related to patient characteristics and not fracture type. A nationwide cohort study. Osteoporosis International 31:5, pages 951-959.
Crossref
Crossref
Mary DiGiulio, Thomas Loveless, Gerti Heider, Kathleen Fagan & Barbara Porsche. (2020) Bisphosphonate drug holidays. The Nurse Practitioner 45:3, pages 50-55.
Crossref
Crossref
Kousuke Iba, Junichi Takada, Tomoko Sonoda & Toshihiko Yamashita. (2019) Effect of continuous long-term treatment for 10 years with bisphosphonate on Japanese osteoporosis patients. Journal of Bone and Mineral Metabolism 38:2, pages 240-247.
Crossref
Crossref
N.H. Rasmussen, J. Dal, F. de Vries, J.P. van den Bergh, M.H. Jensen & P. Vestergaard. (2019) Diabetes and fractures: new evidence of atypical femoral fractures?. Osteoporosis International 31:3, pages 447-455.
Crossref
Crossref
De‐Yi Yan, Jiahao Tang, Liang Chen, Bingzhang Wang, Sheji Weng, Zhongjie Xie, Zong‐Yi Wu, Zijian Shen, Bingli Bai & Lei Yang. (2019) Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β‐catenin pathways. Journal of Cellular and Molecular Medicine 24:3, pages 2330-2341.
Crossref
Crossref
Dong-Soo Kim, Ji-Kang Park, Eui-Sung Choi, Ho-Seung Jeong, Seok-Hyun Hong & Byung-Hyun Ahn. (2020) Treatment of Atypical Ulnar Fracture Associated with Bisphosphonate Therapy: A Case Report. Journal of the Korean Fracture Society 33:2, pages 101.
Crossref
Crossref
Arthur C. SantoraIIII & Anupa Sharma. 2020. Osteoporosis. Osteoporosis
277
307
.
Yoshihiro Kushida, Kazuhiko Omori, Ken-ichi Muramatsu, Hiroki Nagasawa, Ikuto Takeuchi, Kei Jitsuiki, Hiromichi Ohsaka, Yasumasa Oode, Hiroshi Ito & Youichi Yanagawa. (2019) Epidemiology of a Femur Shaft Fracture in an Acute Critical Care Center in a Rural Area of Japan. The Open Orthopaedics Journal 13:1, pages 295-299.
Crossref
Crossref
Vidita Divan, Sudhaker D. Rao & Ruban Dhaliwal. (2019) Detection and management of atypical femur fractures. Current Opinion in Endocrinology, Diabetes & Obesity 26:6, pages 283-290.
Crossref
Crossref
M.A. Png, P.C. Mohan, J.S.B. Koh, C.Y. Howe & T.S. Howe. (2019) Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up. Osteoporosis International 30:12, pages 2417-2428.
Crossref
Crossref
H.-K. Min, J.-H. Ahn, K.-Y. Ha, Y.-H. Kim, S.-I. Kim, H.-Y. Park, K.-W. Rhyu, Y.-Y. Kim, I.-S. Oh, J.-Y. Seo, D.-G. Chang & J.-H. Cho. (2019) Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study. Osteoporosis International 30:11, pages 2249-2256.
Crossref
Crossref
Kunihisa Nezu, Yuji Endo, Hiromichi Katayama, Yoshihiro Nozawa & Atsushi Kyan. (2019) Case of atypical femoral fractures that mimicked the typical imaging findings of prostate cancer‐induced bone metastasis. IJU Case Reports 2:6, pages 303-306.
Crossref
Crossref
Angela M. Cheung, Malachi J. McKenna, Denise M. van de Laarschot, M. Carola Zillikens, Valerie Peck, Jeevitha Srighanthan & E. Michael Lewiecki. (2019) Detection of Atypical Femur Fractures. Journal of Clinical Densitometry 22:4, pages 506-516.
Crossref
Crossref
Ifaz T. Haider, Prism S. Schneider & W. Brent Edwards. (2019) The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture. Current Osteoporosis Reports 17:5, pages 281-290.
Crossref
Crossref
Kate Rassie, Michael Dray, Toshimi Michigami & Tim Cundy. (2019) Bisphosphonate Use and Fractures in Adults with Hypophosphatasia. JBMR Plus 3:10.
Crossref
Crossref
Hiroki Ito, Naohisa Miyakoshi, Yuji Kasukawa, Takeshi Sato, Hitoshi Kubota, Hiroshi Sasaki, Takashi Mizutani & Yoichi Shimada. (2019) Treatment of Atypical Fracture of the Ulnar Diaphysis by Open Reduction and Internal Fixation with Teriparatide. Case Reports in Orthopedics 2019, pages 1-5.
Crossref
Crossref
E.M. Dennison, C. Cooper, J.A. Kanis, O. Bruyère, S. Silverman, E. McCloskey, B. Abrahamsen, D. Prieto-Alhambra & S. Ferrari. (2019) Fracture risk following intermission of osteoporosis therapy. Osteoporosis International 30:9, pages 1733-1743.
Crossref
Crossref
Howard A. FinkRoderick MacDonaldMary L. ForteChristina E. RosebushKristine E. EnsrudJohn T. SchousboeVictoria A. NelsonKristen UllmanMary ButlerCarin M. OlsonBrent C. TaylorMichelle BrasureTimothy J. Wilt. (2019) Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention. Annals of Internal Medicine 171:1, pages 37.
Crossref
Crossref
Michael Kriegbaum Skjødt, Morten Frost & Bo Abrahamsen. (2018) Side effects of drugs for osteoporosis and metastatic bone disease. British Journal of Clinical Pharmacology 85:6, pages 1063-1071.
Crossref
Crossref
Richard Eastell, Clifford J Rosen, Dennis M Black, Angela M Cheung, M Hassan Murad & Dolores Shoback. (2019) Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 104:5, pages 1595-1622.
Crossref
Crossref
Dennis M Black, Bo Abrahamsen, Mary L Bouxsein, Thomas Einhorn & Nicola Napoli. (2019) Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. Endocrine Reviews 40:2, pages 333-368.
Crossref
Crossref
Venthan Jeyaratnam Mailoo, Vidya Srinivas, Jeremy Turner & William Duncan Fraser. (2019) Beware of bone pain with bisphosphonates. BMJ Case Reports 12:3, pages e225385.
Crossref
Crossref
John A Eisman & Christopher P White. (2018) Dispelling confusion about de‐prescribing bisphosphonates. Medical Journal of Australia 210:1, pages 17-19.
Crossref
Crossref
Matthew A. Frank & Hassan R. Mir. 2019. Periprosthetic Fractures of the Hip and Knee. Periprosthetic Fractures of the Hip and Knee
3
18
.
Michal Lisnyansky, Noa Kapelushnik, Ariel Ben-Bassat, Milit Marom, Anat Loewenstein, Daniel Khananshvili, Moshe Giladi & Yoni Haitin. (2018) Reduced Activity of Geranylgeranyl Diphosphate Synthase Mutant Is Involved in Bisphosphonate-Induced Atypical Fractures. Molecular Pharmacology 94:6, pages 1391-1400.
Crossref
Crossref
Bo Abrahamsen & Daniel Prieto‐Alhambra. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
579
587
.
Rowan S Hardy, Hong Zhou, Markus J Seibel & Mark S Cooper. (2018) Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy. Endocrine Reviews 39:5, pages 519-548.
Crossref
Crossref
Ahmet Demirtas & Ani Ural. (2018) Interaction of Microcracks and Tissue Compositional Heterogeneity in Determining Fracture Resistance of Human Cortical Bone. Journal of Biomechanical Engineering 140:9.
Crossref
Crossref
Zongyi Wu, Sheji Weng, Deyi Yan, Zhongjie Xie, Qiang Zhou, Hang Li, Bingli Bai, Viraj Boodhun, Zijian Shen, Jiahao Tang, Lingling Zhou, Zhoushan Tao & Lei Yang. (2018) Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro. Journal of Pharmacological Sciences 138:1, pages 63-70.
Crossref
Crossref
Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Alejandro Román González, Alexandra Terront Lozano, Amanda Páez Talero, Camilo Rueda Belt, Carlos Alfonso Builes Barrera, Carlos Augusto Pérez Niño, Daniel G. Fernández Ávila, David Vásquez Awad, Deyanira González Devia, Edgar Pinilla Pabón, Eduardo Antonio Reina Valdivieso, Esdras Martín Vásquez Mejía, Francisco Iván Vargas Grajales, Francisco Linares Restrepo, Geraldine Altamar Canales, Gustavo Adolfo Molina Uribe, Gustavo Adolfo Pineda Acero, Henry Mauricio Arenas Quintero, Jorge Augusto Vélez Patiño, José Fernando Molina Restrepo, Juan José Jaller Raad, Ricardo Londoño Gutiérrez, Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Patricia Clark, Orlando Angulo Ceballos & Carlos Federico Molina Castaño. (2018) Second Colombian Consensus on the Management of Post-menopausal Osteoporosis: 2017 update. Revista Colombiana de Reumatología (English Edition) 25:3, pages 184-210.
Crossref
Crossref
Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Alejandro Román González, Alexandra Terront Lozano, Amanda Páez Talero, Camilo Rueda Beltz, Carlos Alfonso Builes Barrera, Carlos Augusto Pérez Niño, Daniel G. Fernández Ávila, David Vásquez Awad, Deyanira González Devia, Edgar Pinilla Pabón, Eduardo Antonio Reina Valdivieso, Esdras Martín Vásquez Mejía, Francisco Iván Vargas Grajales, Francisco Linares Restrepo, Geraldine Altamar Canales, Gustavo Adolfo Molina Uribe, Gustavo Adolfo Pineda Acero, Henry Mauricio Arenas Quintero, Jorge Augusto Vélez Patiño, José Fernando Molina Restrepo, Juan José Jaller Raad & Ricardo Londoño Gutiérrez. (2018) II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Revista Colombiana de Reumatología 25:3, pages 184-210.
Crossref
Crossref
Somaye Fallahnezhad, Abdollah Amini, Behnam Hajihossainlou, Sufan Chien, Sara Dadras, Fatemehalsadat Rezaei & Mohammad Bayat. (2018) Combined effects of photobiomodulation and alendronate on viability of osteoporotic bone marrow-derived mesenchymal stem cells. Journal of Photochemistry and Photobiology B: Biology 182, pages 77-84.
Crossref
Crossref
Mohammad Al-Ashqar, Michalis Panteli, Gautam Chakrabarty & Peter V. Giannoudis. (2018) Atypical fractures: An issue of concern or a myth?. Injury 49:3, pages 649-655.
Crossref
Crossref
Dominic Davenport, James Duncan, Robert Duncan, Alastair Dick, Mohit Bansal & Max R. Edwards. (2018) Outcomes for Elderly Patients With Atypical Femoral Fractures Compared to Typical Femoral Fractures for Length of Stay, Discharge Destination, and 30-Day Mortality Rate. Geriatric Orthopaedic Surgery & Rehabilitation 9, pages 215145931882022.
Crossref
Crossref
Francisco Schumacher. (2017) Simultaneous Bilateral Atypical Femoral Fracture: Case Presentation. MOJ Orthopedics & Rheumatology 9:5.
Crossref
Crossref
Carlos Roberto Schwartsmann. (2017) Bilateral Atypical Femur Fracture after Prolonged Use of Alendronate - A Case Report. MOJ Orthopedics & Rheumatology 9:5.
Crossref
Crossref
Neil Eisenstein, Ganesh Kasavkar, Dhruva Bhavsar, Faisal Shehzaad Khan & Zoe Paskins. (2017) Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study. BMC Musculoskeletal Disorders 18:1.
Crossref
Crossref
Muhammad Baig. (2017) Role of bisphosphonates in treatment of osteoporosis in community. atypical periprosthetic sub trochanteric femur fractures during bisphosphonates therapy, a case report. International Journal of Family & Community Medicine 1:2.
Crossref
Crossref
Rui Zhao, Pengfei Xie, Kun Zhang, Zhurong Tang, Xuening Chen, Xiangdong Zhu, Yujiang Fan, Xiao Yang & Xingdong Zhang. (2017) Selective effect of hydroxyapatite nanoparticles on osteoporotic and healthy bone formation correlates with intracellular calcium homeostasis regulation. Acta Biomaterialia 59, pages 338-350.
Crossref
Crossref
Mario Pedrazzoni, Andrea Giusti, Giuseppe Girasole, Barbara Abbate, Ignazio Verzicco & Gianfranco Cervellin. (2016) Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007–2013). Journal of Bone and Mineral Metabolism 35:5, pages 562-570.
Crossref
Crossref
H. P. Bögl, P. Aspenberg & J. Schilcher. (2017) Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series. Osteoporosis International 28:8, pages 2439-2444.
Crossref
Crossref
M. K. JavaidR. HandleyM. L. Costa. (2017) Clinical management and pathogenesis of atypical fractures of the femur. The Bone & Joint Journal 99-B:3, pages 291-294.
Crossref
Crossref
J. SchilcherL. PalmI. IvarssonP. Aspenberg. (2017) Local bisphosphonate reduces migration and formation of radiolucent lines adjacent to cemented acetabular components. The Bone & Joint Journal 99-B:3, pages 317-324.
Crossref
Crossref
Jae-Woo Cho, Chang-Wug Oh, Frankie Leung, Ki-Chul Park, Merng Koon Wong, Ernest Kwek, Han-Ju Kim & Jong-Keon Oh. (2017) Healing of Atypical Subtrochanteric Femur Fractures After Cephalomedullary Nailing: Which Factors Predict Union?. Journal of Orthopaedic Trauma 31:3, pages 138-145.
Crossref
Crossref
Moin Khan, Angela M. Cheung & Aliya A. Khan. (2017) Drug-Related Adverse Events of Osteoporosis Therapy. Endocrinology and Metabolism Clinics of North America 46:1, pages 181-192.
Crossref
Crossref
Dirk Keiner. (2017) Gendermedizin: „Wir stehen erst am Anfang“. Deutsches Ärzteblatt Online.
Crossref
Crossref
Kareeann S.F. Khow, Felix Paterson, Pazhvoor Shibu, Solomon C.Y. Yu, Mellick J. Chehade & Renuka Visvanathan. (2017) Outcomes between older adults with atypical and typical femoral fractures are comparable. Injury 48:2, pages 394-398.
Crossref
Crossref
W.C. Shin, N.H. Moon, J.H. Jang, K.Y. Park & K.T. Suh. (2017) Anterolateral femoral bowing and loss of thigh muscle are associated with occurrence of atypical femoral fracture: Effect of failed tension band mechanism in mid-thigh. Journal of Orthopaedic Science 22:1, pages 99-104.
Crossref
Crossref
B.L. Furman. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Timothy Bhattacharyya, Smita Jha, Hongying Wang, Daniel L. Kastner & Elaine F. Remmers. (2016) Hypophosphatasia and the risk of atypical femur fractures: a case–control study. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Giuseppe Toro, Cristina Ojeda-Thies, Giampiero Calabrò, Gabriella Toro, Antimo Moretti, Guillermo Martínez-Díaz Guerra, Pedro Caba-Doussoux & Giovanni Iolascon. (2016) Management of atypical femoral fracture: a scoping review and comprehensive algorithm. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Shenghan Lou, Houchen Lv, Guoqi Wang, Zhirui Li, Ming Li, Licheng Zhang & Peifu Tang. (2016) The effect of sequential therapy for postmenopausal women with osteoporosis. Medicine 95:49, pages e5496.
Crossref
Crossref
Susan M. Ott. (2016) Long-term bisphosphonates: primum non nocere. Menopause 23:11, pages 1159-1161.
Crossref
Crossref
Ahmet Demirtas, Erin Curran & Ani Ural. (2016) Assessment of the effect of reduced compositional heterogeneity on fracture resistance of human cortical bone using finite element modeling. Bone 91, pages 92-101.
Crossref
Crossref
Valesca Sander Koth, Maria Antonia Figueiredo, Fernanda Gon?alves Salum & Karen Cherubini. (2016)
Bisphosphonate-related osteonecrosis of the jaw: from the
sine qua non
condition of bone exposure to a non-exposed BRONJ entity
. Dentomaxillofacial Radiology 45:7, pages 20160049.
Crossref
Crossref
Laurianne Imbert & Adele Boskey. (2016) Effects of Drugs on Bone Quality. Clinical Reviews in Bone and Mineral Metabolism 14:3, pages 167-196.
Crossref
Crossref
Jennifer L. Favinger, Daniel Hippe & Alice S. Ha. (2016) Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures. Skeletal Radiology 45:5, pages 627-633.
Crossref
Crossref
Juan de Dios Robinson, Ross K. Leighton, Kelly Trask, Yelena Bogdan & Paul Tornetta. (2016) Periprosthetic Atypical Femoral Fractures in Patients on Long-term Bisphosphonates. Journal of Orthopaedic Trauma 30:4, pages 170-176.
Crossref
Crossref
Joan C. Lo, Rita L. Hui, Christopher D. Grimsrud, Malini Chandra, Romain S. Neugebauer, Joel R. Gonzalez, Amer Budayr, Gene Lau & Bruce Ettinger. (2016) The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85, pages 142-147.
Crossref
Crossref
Roman Thaler, Antonio Maurizi, Paul Roschger, Ines Sturmlechner, Farzaneh Khani, Silvia Spitzer, Monika Rumpler, Jochen Zwerina, Heidrun Karlic, Amel Dudakovic, Klaus Klaushofer, Anna Teti, Nadia Rucci, Franz Varga & Andre J. van Wijnen. (2016) Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate. Journal of Biological Chemistry 291:13, pages 6754-6771.
Crossref
Crossref
S. L. Silverman, J. D. Adachi & E. Dennison. (2015) Bisphosphonate drug holidays: we reap what we sow. Osteoporosis International 27:3, pages 849-852.
Crossref
Crossref
Mohammad Kharazmi, Pär Hallberg, Jörg Schilcher, Per Aspenberg & Karl Michaëlsson. (2016) Mortality After Atypical Femoral Fractures: A Cohort Study. Journal of Bone and Mineral Research 31:3, pages 491-497.
Crossref
Crossref
Sungjun KimHyun Hee BangHanna YooIl Hyung ParkKyu Hyun YangHyunsun LimWoo Seok Jung. (2016) Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents. Journal of Bone Metabolism 23:2, pages 85.
Crossref
Crossref
Per Aspenberg. (2016) Atypical fractures, a biased perspective. Injury 47, pages S28-S30.
Crossref
Crossref
B.L. Furman. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Young Sung Kim, Phil Hyun Chung, Suk Kang, Jong Pil Kim, Ho Min Lee & Han Sol Moon. (2015) A rare case of bilateral proximal femoral insufficiency fractures after interlocking IM nailing for bilateral atypical femoral shaft fractures. Archives of Orthopaedic and Trauma Surgery 135:9, pages 1227-1232.
Crossref
Crossref
Ian R. Reid. (2015) Short-term and long-term effects of osteoporosis therapies. Nature Reviews Endocrinology 11:7, pages 418-428.
Crossref
Crossref
. (2015) Research. Bone & Joint 360 4:2, pages 32-34.
Crossref
Crossref